Crescent Capital BDC, Inc.
Crescent Capital BDC, Inc. (CCAP) Financial Performance & Income Statement Overview
Review Crescent Capital BDC, Inc. (CCAP) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Crescent Capital BDC, Inc. (CCAP) Income Statement & Financial Overview
Explore comprehensive income reports for Crescent Capital BDC, Inc. CCAP, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $12.39M | $51.63M | $45.40M | $50.20M |
| Cost of Revenue | $0.00 | $0.00 | $9.60M | $9.84M |
| Gross Profit | $12.39M | $51.63M | $35.79M | $40.36M |
| Gross Profit Ratio | $1.00 | $1.00 | $0.79 | $0.80 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.35M | $1.34M | $1.28M | $1.23M |
| Operating Expenses | $2.29M | $1.19M | $2.27M | -$3.29M |
| Total Costs & Expenses | $2.29M | $1.19M | $8.32M | $6.56M |
| Interest Income | $43.40M | $47.88M | $45.51M | $46.15M |
| Interest Expense | $14.12M | $15.24M | $14.91M | $14.66M |
| Depreciation & Amortization | $0.00 | $0.00 | -$38.07M | -$39.29M |
| EBITDA | $25.93M | $0.00 | $0.00 | $0.00 |
| EBITDA Ratio | $2.09 | $0.00 | $0.00 | $0.00 |
| Operating Income | $10.09M | $50.44M | $38.07M | $43.65M |
| Operating Income Ratio | $0.81 | $0.98 | $0.84 | $0.87 |
| Other Income/Expenses (Net) | $0.00 | -$34.46M | -$17.43M | -$11.26M |
| Income Before Tax | $10.09M | $15.98M | $20.64M | $28.03M |
| Income Before Tax Ratio | $0.81 | $0.31 | $0.45 | $0.56 |
| Income Tax Expense | $100000.00 | $711000.00 | $252000.00 | $27000.00 |
| Net Income | $9.99M | $15.27M | $20.39M | $28.005M |
| Net Income Ratio | $0.81 | $0.30 | $0.45 | $0.56 |
| EPS | $0.27 | $0.64 | $0.55 | $0.76 |
| Diluted EPS | $0.27 | $0.64 | $0.55 | $0.76 |
| Weighted Avg Shares Outstanding | $37.06M | $37.06M | $37.06M | $37.06M |
| Weighted Avg Shares Outstanding (Diluted) | $37.06M | $37.06M | $37.06M | $37.06M |
Over the last four quarters, Crescent Capital BDC, Inc. achieved steady financial progress, growing revenue from $50.20M in Q1 2024 to $12.39M in Q4 2024. Gross profit stayed firm with margins at 100% in Q4 2024 versus 80% in Q1 2024. Operating income totaled $10.09M in Q4 2024, maintaining a 81% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $25.93M. Net income dropped to $9.99M, with EPS at $0.27. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan